Morad Ansari,Kamli N W Faour,Akiko Shimamura,Graeme Grimes,Emeline M Kao,Erica R Denhoff,Ana Blatnik,Daniel Ben-Isvy,Lily Wang,Benjamin M Helm,Helen Firth,Amy M Breman,Emilia K Bijlsma,Aiko Iwata-Otsubo,Thomy J L de Ravel,Vincent Fusaro,Alan Fryer,Keith Nykamp,Lara G Stühn,Tobias B Haack,G Christoph Korenke,Panayiotis Constantinou,Kinga M Bujakowska,Karen J Low,Emily Place,Jennifer Humberson,Melanie P Napier,Jessica Hoffman,Jane Juusola,Matthew A Deardorff,Wanqing Shao,Shira Rockowitz,Ian Krantz,Maninder Kaur,Sarah Raible,Sabine Kliesch,Moriel Singer-Berk,Emily Groopman,Stephanie DiTroia,Sonia Ballal,Siddharth Srivastava,Kathrin Rothfelder,Saskia Biskup,Jessica Rzasa,Jennifer Kerkhof,Haley McConkey,Anne O'Donnell-Luria,Bekim Sadikovic,Sarah Hilton,Siddharth Banka,Frank Tüttelmann,Donald Conrad,Michael E Talkowski,David R FitzPatrick,Philip M Boone

Abstract:Heterozygous missense variants and in-frame indels in SMC3 are a cause of Cornelia de Lange syndrome (CdLS), marked by intellectual disability, growth deficiency, and dysmorphism, via an apparent dominant-negative mechanism. However, the spectrum of manifestations associated with SMC3 loss-of-function variants has not been reported, leading to hypotheses of alternative phenotypes or even developmental lethality. We used matchmaking servers, patient registries, and other resources to identify individuals with heterozygous, predicted loss-of-function (pLoF) variants in SMC3, and analyzed population databases to characterize mutational intolerance in this gene. Here, we show that SMC3 behaves as an archetypal haploinsufficient gene: it is highly constrained against pLoF variants, strongly depleted for missense variants, and pLoF variants are associated with a range of developmental phenotypes. Among 13 individuals with SMC3 pLoF variants, phenotypes were variable but coalesced on low growth parameters, developmental delay/intellectual disability, and dysmorphism reminiscent of atypical CdLS. Comparisons to individuals with SMC3 missense/in-frame indel variants demonstrated a milder presentation in pLoF carriers. Furthermore, several individuals harboring pLoF variants in SMC3 were nonpenetrant for growth, developmental, and/or dysmorphic features, some instead having intriguing symptomatologies with rational biological links to SMC3 including bone marrow failure, acute myeloid leukemia, and Coats retinal vasculopathy. Analyses of transcriptomic and epigenetic data suggest that SMC3 pLoF variants reduce SMC3 expression but do not result in a blood DNA methylation signature clustering with that of CdLS, and that the global transcriptional signature of SMC3 loss is model-dependent. Our finding of substantial population-scale LoF intolerance in concert with variable penetrance in subjects with SMC3 pLoF variants expands the scope of cohesinopathies, informs on their allelic architecture, and suggests the existence of additional clearly LoF-constrained genes whose disease links will be confirmed only by multi-layered genomic data paired with careful phenotyping.

SCYL2‐related autosomal recessive neurodevelopmental disorders: Arthrogryposis multiplex congenita‐4 and beyond?

Further description of two individuals with de novo p.(Glu127Lys) missense variant in the ASCL1 gene

CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems

Further delineation of the SCAF4 -associated neurodevelopmental disorder

Bi-allelic SNAPC4 variants dysregulate global alternative splicing and lead to neuroregression and progressive spastic paraparesis

Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism

Congenital posterior cervical spine malformation due to biallelic c.240‐4T>G RIPPLY2 variant: A discrete entity

Heterozygous loss-of-function SMC3 variants are associated with variable growth and developmental features

De novo loss-of-function mutations in X-linked SMC1A cause severe ID and therapy-resistant epilepsy in females: expanding the phenotypic spectrum

Heterozygous loss-of-function SMC3 variants are associated with variable and incompletely penetrant growth and developmental features

Recurrent Acute Liver Failure Associated with Novel SCYL1 Mutation: A Case Report

DYNC2H1 splicing variants causing severe prenatal short‐rib polydactyly syndrome and postnatal orofaciodigital syndrome

De novo SCAMP5 mutation causes a neurodevelopmental disorder with autistic features and seizures

Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency

Expanding the phenotypic spectrum of ARCN1-related syndrome

SMC1A epilepsy syndrome: clinical data from a large international cohort

Expanding the Mutational Landscape and Clinical Phenotype of CHD2-Related Encephalopathy

Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

Old Gene, New Phenotype: Mutations in Heparan Sulfate Synthesis Enzyme, EXT2 Leads to Seizure and Developmental Disorder, No Exostoses

De Novo Pathogenic Variant in FBRSL1, Non OMIM Gene Paralogue AUTS2, Causes a Novel Recognizable Syndromic Manifestation with Intellectual Disability; An Additional Patient and Review of the Literature

Resolution of SLC6A1 variable expressivity in a multi-generational family using deep clinical phenotyping and Drosophila models